These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 2066647

  • 1. Transport kinetics of pseudouridine during hemodialysis and continuous ambulatory peritoneal dialysis.
    Struijk DG, Schoots AC, Koole LH, van der Reijden HJ, Koomen GC, Krediet RT, Arisz L.
    J Lab Clin Med; 1991 Jul; 118(1):74-80. PubMed ID: 2066647
    [Abstract] [Full Text] [Related]

  • 2. Effect of amino acid based dialysate on peritoneal blood flow and permeability in stable CAPD patients: a potential role for nitric oxide?
    Douma CE, de Waart DR, Struijk DG, Krediet RT.
    Clin Nephrol; 1996 May; 45(5):295-302. PubMed ID: 8738660
    [Abstract] [Full Text] [Related]

  • 3. Dialysate to plasma solute concentration (D/P) versus peritoneal transport parameters in CAPD.
    Heimbürger O, Waniewski J, Werynski A, Park MS, Lindholm B.
    Nephrol Dial Transplant; 1994 May; 9(1):47-59. PubMed ID: 8177476
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Calcium mass transfer and kinetics in CAPD using calcium-free solutions.
    Malberti F, Corradi B, Imbasciati E.
    Adv Perit Dial; 1993 May; 9():274-9. PubMed ID: 8105942
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Peritoneal functional changes induced by dialysate containing bicarbonate instead of lactate.
    Selgas R, Bajo MA, Fernandez-Reyes MJ, Jimenez C, Del Peso G, Sanchez C, de Alvaro F.
    Adv Perit Dial; 1996 May; 12():49-52. PubMed ID: 8865872
    [Abstract] [Full Text] [Related]

  • 10. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
    Janda K, Stompór T, Gryz E, Szczudlik A, Drozdz M, Kraśniak A, Sułowicz W.
    Przegl Lek; 2007 May; 64(6):423-30. PubMed ID: 18159852
    [Abstract] [Full Text] [Related]

  • 11. Outcome for continuous ambulatory peritoneal dialysis patients is not predicted by peritoneal permeability characteristics.
    Passadakis PS, Thodis ED, Panagoutsos SA, Selisiou CA, Pitta EM, Vargemezis VA.
    Adv Perit Dial; 2000 May; 16():2-6. PubMed ID: 11045251
    [Abstract] [Full Text] [Related]

  • 12. Deficiency of serum ionized magnesium in patients receiving hemodialysis or peritoneal dialysis.
    Markell MS, Altura BT, Sarn Y, Delano BG, Ifudu O, Friedman EA, Altura BM.
    ASAIO J; 1993 May; 39(3):M801-4. PubMed ID: 8268649
    [Abstract] [Full Text] [Related]

  • 13. Nitrate in stable CAPD patients and during peritonitis.
    Douma CE, de Waart DR, Zemel D, Imholz AL, Koomen GC, Struijk DG, Krediet RT.
    Adv Perit Dial; 1995 May; 11():36-40. PubMed ID: 8534733
    [Abstract] [Full Text] [Related]

  • 14. Liquid-chromatographic profiling of solutes in serum of uremic patients undergoing hemodialysis and chronic ambulatory peritoneal dialysis (CAPD); high concentrations of pseudouridine in CAPD patients.
    Schoots AC, Gerlag PG, Mulder AW, Peeters JA, Cramers CA.
    Clin Chem; 1988 Jan; 34(1):91-7. PubMed ID: 3338190
    [Abstract] [Full Text] [Related]

  • 15. Ultrafiltration failure and dialysate glucose in CAPD.
    Stegmayr B, Granbom L, Karlsson UM, Lindqvist B.
    Adv Perit Dial; 1993 Jan; 9():62-4. PubMed ID: 8105964
    [Abstract] [Full Text] [Related]

  • 16. Continuous ambulatory peritoneal dialysis with a high flux membrane. A preliminary report.
    Nolph KD, Moore HL, Prowant B, Twardowski ZJ, Khanna R, Gamboa S, Keshaviah P.
    ASAIO J; 1993 Jan; 39(3):M566-8. PubMed ID: 8268600
    [Abstract] [Full Text] [Related]

  • 17. Neutral-pH peritoneal dialysis solution improves peritoneal function and decreases matrix metalloproteinase-2 (MMP-2) in patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
    Nishina M, Endoh M, Suzuki D, Tanabe R, Endoh H, Hirahara I, Sakai H.
    Clin Exp Nephrol; 2004 Dec; 8(4):339-43. PubMed ID: 15619033
    [Abstract] [Full Text] [Related]

  • 18. Continuous ambulatory peritoneal dialysis with a high flux membrane.
    Nolph KD, Moore HL, Prowant B, Twardowski ZJ, Khanna R, Gamboa S, Keshaviah P.
    ASAIO J; 1993 Dec; 39(4):904-9. PubMed ID: 8123925
    [Abstract] [Full Text] [Related]

  • 19. Aluminum concentrations in serum, dialysate, urine and bone among patients undergoing continuous ambulatory peritoneal dialysis (CAPD).
    Joffe P, Olsen F, Heaf JG, Gammelgaard B, Pödenphant J.
    Clin Nephrol; 1989 Sep; 32(3):133-8. PubMed ID: 2791364
    [Abstract] [Full Text] [Related]

  • 20. The effect of change of renal replacement therapy on serum lipoprotein (a) concentration.
    Misra M, Webb AT, Reaveley DA, Doherty E, O'Donnell M, Seed M, Brown EA.
    Adv Perit Dial; 1997 Sep; 13():168-73. PubMed ID: 9360675
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.